These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19400554)

  • 1. A cure Weibull gamma-frailty survival model and its application to exploring the prognosis factors of neuroblastoma.
    Dokhi M; Ohtaki M; Hiyama E
    Hiroshima J Med Sci; 2009 Mar; 58(1):25-35. PubMed ID: 19400554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian cure rate frailty models with application to a root canal therapy study.
    Yin G
    Biometrics; 2005 Jun; 61(2):552-8. PubMed ID: 16011704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-rank hazard regression for modelling non-proportional hazards.
    Perperoglou A; le Cessie S; van Houwelingen HC
    Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nested frailty models using maximum penalized likelihood estimation.
    Rondeau V; Filleul L; Joly P
    Stat Med; 2006 Dec; 25(23):4036-52. PubMed ID: 16463308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression models for infant mortality data in Norwegian siblings, using a compound Poisson frailty distribution with random scale.
    Moger TA; Aalen OO
    Biostatistics; 2008 Jul; 9(3):577-91. PubMed ID: 18304994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of time to death after transplantation when transplants are only given to patients in remission.
    Stram DO; Sather H; Wang L
    Biometrics; 1996 Sep; 52(3):1079-86. PubMed ID: 8805769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations of neuroblastoma in children and their effect on prognosis].
    Stanković T; Bunjevacki G; Stojimirović E; Dotlić R; Lukac R
    Srp Arh Celok Lek; 1989; 117(7-8):473-81. PubMed ID: 2595472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of neuroblastoma: analysis of a single institution.
    Izbicki T; Mazur J; Izbicka E
    Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroblastoma: diagnosis and therapy].
    Wargalla-Plate U; Hero B; Berthold F
    Praxis (Bern 1994); 1995 Oct; 84(41):1152-7. PubMed ID: 7481325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SAS macro for parametric and semiparametric mixture cure models.
    Corbière F; Joly P
    Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the proportion of cured patients in a censored sample.
    Lam KF; Fong DY; Tang OY
    Stat Med; 2005 Jun; 24(12):1865-79. PubMed ID: 15900587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy.
    Binquet C; Abrahamowicz M; Mahboubi A; Jooste V; Faivre J; Bonithon-Kopp C; Quantin C
    Stat Med; 2008 Dec; 27(30):6470-88. PubMed ID: 18837067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty modeling for spatially correlated survival data, with application to infant mortality in Minnesota.
    Banerjee S; Wall MM; Carlin BP
    Biostatistics; 2003 Jan; 4(1):123-42. PubMed ID: 12925334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma. Management and survival.
    Lingley JF; Sagerman RH; Santulli TV; Wolff JA
    N Engl J Med; 1967 Dec; 277(23):1227-30. PubMed ID: 6058611
    [No Abstract]   [Full Text] [Related]  

  • 18. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.
    Hsu L; Gorfine M; Malone K
    Stat Med; 2007 Nov; 26(25):4657-78. PubMed ID: 17348081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportional hazards models with frailties and random effects.
    O'Quigley J; Stare J
    Stat Med; 2002 Nov; 21(21):3219-33. PubMed ID: 12375300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment results of neuroblastoma in children in the Republic of Belarus].
    Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
    Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.